Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LIV by WellNow vs LumiMeds

LIV by WellNow
Graded #264

Lower grade

vs+5.500000000000007
LumiMeds
Graded #153

Higher grade

The verdict

LumiMeds takes it — 68.4/100 to 62.9/100.

LumiMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider with flat-rate compounded GLP-1 pricing on a 3-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLumiMeds +25
51
76
Dose & formulationLIV by WellNow +9
73
64
Clinical oversightLumiMeds +3
79
82
Labs & monitoringLumiMeds +1
52
53
FulfillmentLumiMeds +2
63
65
Contract termsEven
55
55
LIV by WellNow · left barLumiMeds · right bar

The numbers

MetricLIV by WellNowLumiMeds
WeighScore62.9/10068.4/100
GradeCC
Scorecard rank#264#153
Semaglutide$279/mo$133/mo (starting dose, compounded)
TirzepatideNot disclosed$133/mo (starting dose, compounded)
Coverage5 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
LIV by WellNow

Graded #264 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide
LumiMeds

Graded #153 · C

Strengths

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard